EP3676271 - THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME [Right-click to bookmark this link] | |||
Former [2020/28] | THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING SAME | ||
[2023/35] | Status | Examination is in progress Status updated on 16.03.2023 Database last updated on 31.08.2024 | |
Former | Request for examination was made Status updated on 05.06.2020 | ||
Former | The international publication has been made Status updated on 08.03.2019 | ||
Former | unknown Status updated on 08.10.2018 | Most recent event Tooltip | 29.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Oregon State University Office for Commercialization & Corporate Development A312 Kerr Administration Building Corvallis, OR 97331-2140 / US | [2020/28] | Inventor(s) | 01 /
BEAUDRY, Chris Office For Commercialization&Corporate Development A312 Kerr Administration Building Corvallis OR 97331-2140 / US | 02 /
HURST, James Office For Commercialization&Corporate Development A312 Kerr Administration Building Corvallis OR 97331-2140 / US | 03 /
BECKMAN, Joseph Office For Commercialization&Corporate Development A312 Kerr Administration Building Corvallis OR 97331-2140 / US | 04 /
SIROIS, John Office For Commercialization&Corporate Development A312 Kerr Administration Building Corvallis OR 97331-2140 / US | [2020/28] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
Former [2020/28] | J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 18778677.7 | 31.08.2018 | [2020/28] | WO2018US49163 | Priority number, date | US201762553714P | 01.09.2017 Original published format: US 201762553714 P | [2020/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019046761 | Date: | 07.03.2019 | Language: | EN | [2019/10] | Type: | A1 Application with search report | No.: | EP3676271 | Date: | 08.07.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.03.2019 takes the place of the publication of the European patent application. | [2020/28] | Search report(s) | International search report - published on: | EP | 07.03.2019 | Classification | IPC: | C07F1/08, A61P25/14, A61K33/34 | [2020/28] | CPC: |
C07F1/005 (EP);
A61K33/34 (EP,US);
A61K31/155 (US);
A61K31/4152 (EP);
A61K31/428 (EP);
A61K31/4545 (US);
| C-Set: |
A61K31/4152, A61K2300/00 (EP);
A61K31/428, A61K2300/00 (EP);
A61K33/34, A61K2300/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/28] | Title | German: | THERAPEUTISCHE METALLKOMPLEXE UND LIGANDEN UND VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON | [2020/28] | English: | THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME | [2023/35] | French: | COMPLEXES DE MÉTAL THÉRAPEUTIQUES ET LIGANDS, LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION | [2020/28] |
Former [2020/28] | THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING SAME | Entry into regional phase | 05.03.2020 | National basic fee paid | 05.03.2020 | Designation fee(s) paid | 05.03.2020 | Examination fee paid | Examination procedure | 05.03.2020 | Examination requested [2020/28] | 05.03.2020 | Date on which the examining division has become responsible | 12.11.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 20.01.2021 | Amendment by applicant (claims and/or description) | 15.03.2023 | Despatch of a communication from the examining division (Time limit: M04) | 24.07.2023 | Reply to a communication from the examining division | Request for further processing for: | 20.01.2021 | Request for further processing filed | 20.01.2021 | Full payment received (date of receipt of payment) Request granted | 29.01.2021 | Decision despatched | Fees paid | Renewal fee | 13.08.2020 | Renewal fee patent year 03 | 13.08.2021 | Renewal fee patent year 04 | 18.07.2022 | Renewal fee patent year 05 | 27.07.2023 | Renewal fee patent year 06 | 29.07.2024 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2008061306 (UNIV MELBOURNE [AU], et al) [X] 1,19,20 * claims 1,91 * [I] 2-18,21-33; | [XI]WO2015070177 (COLLABORATIVE MEDICINAL DEV LLC [US]) [X] 1,19,20 * claims 1,6,13,15 * [I] 2-18,31-33; | [XA]WO2017070752 (UNIV QUEENSLAND [AU]) [X] 1,19 * page 24; claims 1,17,24 * [A] 2-18,20-33; | [XP]WO2017214546 (UNIV LOUISVILLE RES FOUND INC [US]) [XP] 1* claims 1,11 *; | [X] - ZDENA DURACKOVÁ ET AL, "Thiohydrazone copper(II) complexes. The relationship between redox properties and superoxide dismutase mimetic activity", BIOELECTROCHEMISTRY AND BIOENERGETICS., XX, (19990201), vol. 48, no. 1, doi:10.1016/S0302-4598(98)00231-1, ISSN 0302-4598, pages 109 - 116, XP055522960 [X] 1,19 * figure 2; tables 1,3 * DOI: http://dx.doi.org/10.1016/S0302-4598(98)00231-1 | [X] - DEARLING J L J ET AL, "Redox-active metal complexes for imaging hypoxic tissues: Structure-activity relationships in copper(II) bis(thiosemicarbazone) complexes", CHEMICAL COMMUNICATIONS, ROYAL SOCIETY OF CHEMISTRY, (19981121), vol. 4, no. 22, doi:10.1039/A805957H, ISSN 1359-7345, pages 2531 - 2532, XP002405152 [X] 1,19 * abstract * * page 2531, column r, line 1 - line 25 * DOI: http://dx.doi.org/10.1039/a805957h | [X] - EUGENE A. COATS ET AL, "Comparative analysis of the cytotoxicity of substituted [phenylglyoxal bis(4-methyl-3-thiosemicarbazone]copper(II) chelates", JOURNAL OF MEDICINAL CHEMISTRY, (19760101), vol. 19, no. 1, doi:10.1021/jm00223a023, ISSN 0022-2623, pages 131 - 135, XP055522818 [X] 1,2,4,9,19 * abstract * * tables I,III * DOI: http://dx.doi.org/10.1021/jm00223a023 | [X] - EUGENE A. COATS ET AL, "Comparative analysis of the cytotoxicity of substituted [phenylglyoxal bis(4-methyl-3-thiosemicarbazone)]copper(II) chelates. 2. Parabolic correlations and their implications for selective toxicity", JOURNAL OF MEDICINAL CHEMISTRY, (19780801), vol. 21, no. 8, doi:10.1021/jm00206a017, ISSN 0022-2623, pages 804 - 809, XP055030125 [X] 1,4,9,19 * abstract * * tables I-III * DOI: http://dx.doi.org/10.1021/jm00206a017 | [X] - LARRY E. WARREN ET AL, "The mass spectra of some copper(II) complexes related to anti-carcinogens", OMS. ORGANIC MASS SPECTROMETRY., GB, (19710101), vol. 5, no. 1, doi:10.1002/oms.1210050103, ISSN 0030-493X, pages 15 - 18, XP055523014 [X] 1,2,8,19 * abstract * * Scheme 3 * DOI: http://dx.doi.org/10.1002/oms.1210050103 | by applicant | - S. M. BERGE, "Pharmaceutical Salts", J. Pharm. Sci., (19770000), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560 DOI: http://dx.doi.org/10.1002/jps.2600660104 | - "Pro-drugs as Novel Delivery Systems", T. HIGUCHI; V. STELLA, A.C.S. Symposium Series, and in Bioreversible Carriers in Drug Design, American Pharmaceutical Association and Pergamon Press, (19870000), vol. 14 | - HARTWIG, S., Polym. Chem., (20100000), vol. 1, pages 69 - 71 |